NT: We get where you're coming from....you must ha
Post# of 30029
Posted On: 11/19/2014 9:08:04 AM
NT: We get where you're coming from....you must have a very low cost basis. You are not responding to this Lympro revenue thing like a normal investor. That is OK, too. Different strokes for different folks. But I hope you understand our desire for Gerald to address it now!
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼